Phase II trial of bisantrene in advanced colorectal cancer: A cancer and leukemia group B study

M. C. Perry, A. A. Forastiere, F. Richards, R. B. Weiss, D. Anbar

Research output: Contribution to journalArticlepeer-review

Abstract

This phase II trial failed to identify any activity of bisantrene in patients with recurrent or metastatic colorectal cancer who had not received previous chemotherapy for metastatic disease. Side effects were fever, chills, and phlebitis. At this dose and schedule bisantrene is inactive in this disease.

Original languageEnglish (US)
Pages (from-to)1997-1998
Number of pages2
JournalCancer treatment reports
Volume66
Issue number11
StatePublished - 1982
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Phase II trial of bisantrene in advanced colorectal cancer: A cancer and leukemia group B study'. Together they form a unique fingerprint.

Cite this